Caroline Haglund
Impact in
-
- Glioma Diagnosis and Treatment
-
- Piperaceae Chemical and Biological Studies
Papers in
- Oncology 8
- Cancer Cells and Metastasis 3
- Drug Transport and Resistance Mechanisms 2
- Peptidase Inhibition and Analysis 2
-
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Rolf Larsson (14 shared papers)Mårten Fryknäs (8 shared papers)Peter Nygren (4 shared papers)Joachim Gullbo (5 shared papers)Linda Rickardson (5 shared papers)Pádraig D’Arcy (4 shared papers)Stig Linder (4 shared papers)Malin Jarvius (5 shared papers)
- Journals
- Investigational New Drugs (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer Research (1 paper)Oncotarget (1 paper)Cell Reports (1 paper)
- Partner nations
- Sweden
In The Last Decade
Caroline Haglund
14 papers receiving 321 citations
Peers
Comparison fields: 5 of 67
- Genetics 52
- Pharmacology 35
- Oncology 103
- Hematology 39
- Cancer Research 48
Countries citing papers authored by Caroline Haglund
This map shows the geographic impact of Caroline Haglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Haglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Haglund more than expected).
Fields of papers citing papers by Caroline Haglund
This network shows the impact of papers produced by Caroline Haglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Haglund. The network helps show where Caroline Haglund may publish in the future.
Co-authors
The 25 scholars most cited alongside Caroline Haglund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 52 | |
| 2 | 2013 | 50 | |
| 3 | 2011 | 37 | |
| 4 | 2007 | 32 | |
| 5 | 2006 | 31 | |
| 6 | 2019 | 31 | |
| 7 | 2011 | 27 | |
| 8 | 2012 | 20 | |
| 9 | 2010 | 16 | |
| 10 | 2007 | 13 | |
| 11 | 2016 | 13 | |
| 12 | 2014 | 4 | |
| 13 | 2016 | 2 | |
| 14 | 2017 | 1 | |
| 15 | Malignancy and drug sensitivity of glioblastoma cells are affected by the cell of origin | 2016 | 0 |
About Caroline Haglund
Caroline Haglund is a scholar working on Oncology, Molecular Biology, Genetics, Hematology and Immunology, having authored 15 papers that have together received 329 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Cancer Cells and Metastasis (3 papers), MicroRNA in disease regulation (2 papers), Acute Myeloid Leukemia Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Genetics (52 citations), Pharmacology (35 citations), Oncology (103 citations), Hematology (39 citations) and Cancer Research (48 citations). Caroline Haglund has collaborated with scholars based in Sweden. Frequent co-authors include Rolf Larsson, Mårten Fryknäs, Peter Nygren, Joachim Gullbo, Linda Rickardson, Pádraig D’Arcy, Stig Linder, Malin Jarvius, Malin Wickström and Elin Lindhagen. Their work appears in journals such as Investigational New Drugs, Cancer Chemotherapy and Pharmacology, Cancer Research, Oncotarget and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.